Aussie PBS Panel Experts Back Coverage Of Pharmaxis CF Drug
This article was originally published in PharmAsia News
Executive Summary
Australia’s Pharmaceutical Benefits Scheme experts have recommended coverage of the Pharmaxis cystic fibrosis drug, Bronchitol (mannitol), an inhaled powder still in the second of two Phase III trials.